businessgreen_logo
Sign in Join
    • My account
    • Sign out
  • You are currently accessing BusinessGreen via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
logo
  • logo

    Search BusinessGreen

  • News
  • Topics

    Select a Topic below

    In-depth Opinion Energy Policy Management Technology Investment
  • Events
  • BusinessGreen Intelligence
  • More

    Content by subject

    • Energy
    • Investment
    • Management
    • Policy
    • Technology
      • Transport
      • Work
      • Net Zero Now

    Authors

    • James Murray
    • Michael Holder
    • Stuart Stone

    Blogs

    • Editor's Blog
    • Partner Insight

    Connect with us

    • Contact us
    • Newsletter
    • Bluesky
    • X (formerly Twitter)
    • Facebook
    • LinkedIn
    • Instagram
  • Searchlogo

    Search BusinessGreen

    x
Join Sign in
 
    • My account
    • Sign out
  • You are currently accessing BusinessGreen via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
    • Sign in

pharmaceuticals

'World first': AstraZeneca granted UK license for 'near-zero' emission inhaler medicine

Supply chain

'World first': AstraZeneca granted UK license for 'near-zero' emission inhaler medicine

Pharmaceuticals giant claims its respiratory medicine can be used in a new climate friendly inhaler that promises 'near-zero global warming potential'

clock 12 May 2025 • 4 min read
Pharmaceutical giants team up on effort to combat carbon emissions from clinical trials

Supply chain

Pharmaceutical giants team up on effort to combat carbon emissions from clinical trials

Pistoia Alliance brings together likes of AstraZeneca, GSK, and Pfizer to develop industry-wide standard for measuring CO2 from clinical trials

clock 24 March 2025 • 3 min read
Reports: Pharma industry lobbied against proposal for levy on use of digital biodiversity data

Biodiversity

Reports: Pharma industry lobbied against proposal for levy on use of digital biodiversity data

As UK-led negotiations on fairer sharing of biodiversity data continue at COP16, leading pharma companies have allegedly lobbied government against proposals for a mandatory levy

clock 25 October 2024 • 3 min read
GSK hails low emission asthma inhaler breakthrough

Technology

GSK hails low emission asthma inhaler breakthrough

Asthma inhalers account for almost half the pharma giant's carbon footprint, but a new formula promises to slash emissions from the technology by 90 per cent

clock 21 November 2023 • 3 min read
Pharma bosses come together to tackle supply chain emissions

Carbon Accounting

Pharma bosses come together to tackle supply chain emissions

UK firms AstraZeneca and GSK among companies to form new task force designed to firm up emissions standards for health sector and reduce emissions generated by pharmaceutical suppliers

clock 04 November 2022 • 2 min read
'Energize': Pharmaceutical giants collaborate on cure for supply chain emissions

Management

'Energize': Pharmaceutical giants collaborate on cure for supply chain emissions

New 'Energize' programme designed and delivered by Schneider Electric aims to facilitate decarbonisation of electricity for pharma giants' European and US suppliers

clock 09 November 2021 • 4 min read

Management

AstraZeneca promises to get to net zero 10 years ahead of schedule

$1bn 'Ambition Zero Carbon' aims for zero carbon emissions across global operations by 2025, and ensure entire value chain is carbon negative by 2030

clock 23 January 2020 • 2 min read

Supplier

Japanese giant Takeda announces 2040 carbon neutrality goal

The global pharmaceuticals behemoth is planning to reduce emissions by 40 per cent by 2025, CEO Christophe Weber announced yesterday

clock 15 January 2020 • 1 min read
  • Contact Us
  • Marketing Solutions
  • About Incisive Media
  • Privacy Settings
  • Terms & Conditions
  • Policies
  • Careers
FOLLOW US
Incisive Media

© Incisive Business Media Limited, Published by Incisive Business Media Limited, New London House, 172 Drury Lane, London WC2B 5QR. Registered in England and Wales with company registration number 09178013. Part of Arc network, www.arc-network.com

DIGITAL PUBLISHER OF THE YEAR
right wallpaper ad
Loading.gif?page type=listing page&tag=pharmaceuticals